TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07374848: Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

Sponsor: Zai Lab (Shanghai) Co., Ltd. · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 180 pts

Competing Trials Overlap

7 Active Trials

Excess Burn Exposure

$10,053,120

Rescue Site Savings

+$6,628,776

Unlock Full NCT07374848 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07374848 Rescue Dossier →